Fidelitas et AVM fusionnent/

Article Abstract:

Fidea will act as an independent entity within KBC Bancassurance Holding, and will distribute its insurance products through a number of independent intermediaries. Fidea will total almost BFr 8bn in premiums and a consolidated profit of BFr 422mn. The new entity is the result of the merger of Fidelitas (business insurance) and AVM which supplies its insurance services and products to independent entrepreneurs and private individuals. The merger was approved on an extraordinary general meeting of the shareholders of Fidelitas and AVM on 30 June 1998. The operation includes Delphi and Delphi Vie, two subsidiaries of Fidelitas active in the market of private individuals.

Comment:

Merges with Fidelitas to form Fidea insurance co which will act as independent entity within KBC Bancassurance Holding

Acquisitions & mergers, Insurance, Insurance Carriers and Related Activities, Organizational history, Fidea, Fidelitas N.V., AVM

---

Le Belge RED Laboratories met la derni re main un placement priv

Article Abstract:

RED Laboratories, the Belgian biotechnology group is soon going to wrap up a private investment in its company which represents US$ 3mn, or 10% of its equity. The group had already taken in US$ 2.2mn. This money should enable the group to market diagnostic kits in order to reach the 10mn people in the world affected by chronic illness. After this private investment, RED Laboratories' principal shareholder will be a holding company for private interests. Hemispherx, the United States company which is going to introduce a medication for chronic fatigue syndrome, may also take a stake in RED Laboratories.

Comment:

Is soon going to wrap up a private investment in its company which represents $3 mil, or 10% of its equity

Strategy & planning, Pharmaceutical Preparation Manufacturing, Pharmaceutical Preparations, Drugs, RED Laboratories

---

Similar abstracts:

• Abstracts: Pays-Bas/ France/Belgique : La Brasserie Duyck vient de signer un contrat/ La Commission demande Paris de clarifier la loi Evin
• Abstracts: La STIB entre contraintes budg taires et r gionales Concentration croissante de l'activit au port d'Anvers
• Abstracts: El coste de adaptacion se eleva a 200,000 millones Ahorro de 30,000 millones por el 'medicamentazo' Una 'superbotica' en la red
• Abstracts: Nokia puskee Japanin markkinoille Paistopisteet lis v t leiv n kulutusta Sokerittomat virvoitusjuomat maistuvat suomalaisille
• Abstracts: La BBL revoit en baisse ses pr visions/ La Royale Belge vend ses Electrafina et ses Suez

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.